Search Results 21-30 of 13254 for D&C
The Kern Center for the Science of Health Care Delivery works with collaborators from Mayo Clinic and across the country to advance research efforts.
Prior clinical experience with CD38-targeting antibodies, including daratumumab, establish this molecule as an important therapeutic target in multiple ...
Mayo Clinic Laboratories.
Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies · More about research at ...
The Mayo Clinic Kern Center for the Science of Health Care Delivery's multidisciplinary faculty guides research on the delivery of evidence-based, ...
Treatment includes stopping vitamin D intake and restricting dietary calcium. Your doctor might also prescribe intravenous fluids and medications, such as ...
National Vocabulary Knowledge Center.
This research study is being done to determine if a low vitamin D level and mammographic density may be risk factors for developing breast cancer.
The purpose of this single-dose escalation study is to evaluate the safety and effectiveness of CAR2 Anti-CD38 A2 CAR-T Cells in patients with Relapsed or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.